Your search returned 4 results.

Results
	1.	Effect of Gender and Menopausal Status on the Pharmacokinetics of Tirilazad Mesylate in Healthy Subjects. [electronic resource] by Fleishaker, Joseph C Hulst-Pearson, Laura K Peters, Gary R Publication details: American journal of therapeutics Aug 1995 In: American journal of therapeutics vol. 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	No influence of obesity on the pharmacokinetics and pharmacodynamics of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran. [electronic resource] by Sarich, Troy C Teng, Renli Peters, Gary R Wollbratt, Maria Homolka, Robert Svensson, Mia Eriksson, Ulf G Producer: 20030910 In: Clinical pharmacokinetics vol. 42 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement. [electronic resource] by Francis, Charles W Berkowitz, Scott D Comp, Philip C Lieberman, Jay R Ginsberg, Jeffrey S Paiement, Guy Peters, Gary R Roth, Anne W McElhattan, Jennifer Colwell, Clifford W Producer: 20031105 In: The New England journal of medicine vol. 349 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial. [electronic resource] by Francis, Charles W Davidson, Bruce L Berkowitz, Scott D Lotke, Paul A Ginsberg, Jeffrey S Lieberman, Jay R Webster, Anne K Whipple, James P Peters, Gary R Colwell, Clifford W Producer: 20021021 In: Annals of internal medicine vol. 137 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)